Rengyun Liu

机构：Sun Yat-sen University, The First Affiliated Hospital, Sun Yat-sen University · ORCID：0000-0002-1408-2372

发表论文 81 篇 · 总被引 4251 次 · h-index 29

代表论文

• Cellular mechanisms of combining innate immunity activation with PD-1/PD-L1 blockade in treatment of colorectal cancer (2024 · Molecular Cancer · 被引 37)
• Methylation-Mediated Silencing of ATF3 Promotes Thyroid Cancer Progression by Regulating Prognostic Genes in the MAPK and PI3K/AKT Pathways (2023 · Thyroid · 被引 35)
• CircGLIS3 inhibits thyroid cancer invasion and metastasis through miR-146b-3p/AIF1L axis (2023 · Cellular Oncology · 被引 19)
• TERT promoter methylation is associated with high expression of TERT and poor prognosis in papillary thyroid cancer (2024 · Frontiers in Oncology · 被引 17)
• Genetic trio of BRAF and TERT alterations and rs2853669TT in papillary thyroid cancer aggressiveness (2023 · JNCI Journal of the National Cancer Institute · 被引 14)
• TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer (2024 · Cancer Cell International · 被引 11)